1.98 USD
▼-0.02-1.00%
盘后 1.93 -2.53%
2026-09-15
市值
$336.80M
市盈率
—
EPS
-0.77
股息率
—
52 周区间
0.44 – 3.04
成交量
359.64K
Beta
1.60
目标价
4.75
52W 低 0.4452W 高 3.04
价格走势
公司简介
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoim...